TMCI Q4 2023 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena

TMCITreace Medical Concepts, Inc.

$104M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$62M+25.0% YoY

Gross Profit

$51M81.6% margin

Operating Income

-$7M-10.9% margin

Net Income

-$6M-10.1% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+52.6%

Cash Flow

Operating Cash Flow

$532,000

Free Cash Flow

-$2M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$252M

Total Liabilities

$114M

Stockholders' Equity

$138M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$50M	+25.0%
Gross Profit	$51M	$40M	+26.8%
Operating Income	-$7M	-$3M	-93.9%
Net Income	-$6M	-$4M	-42.4%